Gene · 156
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A bead-based GPCR phosphorylation immunoassay for high-throughput ligand profiling and GRK inhibitor screening. | Commun Biol | 2022 | 36352263 | PubTator, text mining | PubMed |
| Global Phosphoproteomics Unveils Kinase-Regulated Networks in Systemic Lupus Erythematosus. | Mol Cell Proteomics | 2022 | 36309313 | PubTator, text mining | PubMed |
| Towards Precision Oncology: The Role of Smoothened and Its Variants in Cancer. | J Pers Med | 2022 | 36294790 | PubTator, text mining | PubMed |
| How Arrestins and GRKs Regulate the Function of Long Chain Fatty Acid Receptors. | Int J Mol Sci | 2022 | 36293091 | PubTator, text mining | PubMed |
| Understanding Mechanisms of RKIP Regulation to Improve the Development of New Diagnostic Tools. | Cancers (Basel) | 2022 | 36291854 | PubTator, text mining | PubMed |
| Biased signaling due to oligomerization of the G protein-coupled platelet-activating factor receptor. | Nat Commun | 2022 | 36289206 | PubTator, text mining | PubMed |
| Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities. | Pharmacol Ther | 2022 | 36283452 | PubTator, text mining | PubMed |
| The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A1-A2A receptor heteromer formation and function. | Biomed Pharmacother | 2022 | 36279718 | PubTator, text mining | PubMed |
| GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2. | Front Immunol | 2022 | 36275707 | PubTator, text mining | PubMed |
| A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. | Nat Commun | 2022 | 36271011 | PubTator, text mining | PubMed |
| Cross-linking of the endolysosomal system reveals potential flotillin structures and cargo. | Nat Commun | 2022 | 36266287 | PubTator, text mining | PubMed |
| Development and assessment of diabetic nephropathy prediction model using hub genes identified by weighted correlation network analysis. | Aging (Albany NY) | 2022 | 36242604 | PubTator, text mining | PubMed |
| Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells. | Int J Mol Sci | 2022 | 36233192 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| Deciphering the Basis of Molecular Biology of Selected Cardiovascular Diseases: A View on Network Medicine. | Int J Mol Sci | 2022 | 36232723 | PubTator, text mining | PubMed |
| Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility. | Int J Mol Sci | 2022 | 36232617 | PubTator, text mining | PubMed |
| The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36230521 | PubTator, text mining | PubMed |
| Effect of mechanical forces on cellular response to radiation. | Radiother Oncol | 2022 | 36228760 | PubTator, text mining | PubMed |
| Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris. | Cardiol Res Pract | 2022 | 36213457 | PubTator, text mining | PubMed |
| CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation. | Cell Biosci | 2022 | 36210463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/156/papers?page=20